Ticker Details
Immunovant, Inc.
IPO Date:	June 7, 2019
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$6.39B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.59 | 2.97%
Avg Daily Range (30 D):	$0.90 | 2.99%
Avg Daily Range (90 D):	$0.70 | 2.55%

Institutional Daily Volume
Avg Daily Volume:	.84M
Avg Daily Volume (30 D):	1.94M
Avg Daily Volume (90 D):	1.41M

Trade Size
Avg Trade Size (Sh.):	76
Avg Trade Size (Sh.) (30 D):	72
Avg Trade Size (Sh.) (90 D):	67

Institutional Trades
Total Institutional Trades:	3,317
Avg Institutional Trade:	$2.34M
Avg Institutional Trade (30 D):	$2.64M
Avg Institutional Trade (90 D):	$2.74M
Avg Institutional Trade Volume:	.1M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$3.77M
Avg Closing Trade (30 D):	$5.29M
Avg Closing Trade (90 D):	$5.13M
Avg Closing Volume:	166.07K

News

Jun 2, 2026 @ 5:00 PM Myasthenia Gravis Clinical Trial Pipeline Expands ... Source: Delveinsight

Apr 15, 2026 @ 5:00 PM Generalized Myasthenia Gravis Market on the Brink ... Source: Delveinsight

Apr 2, 2026 @ 9:00 AM Immunovant Announces Phase 3 Study Results for Bat... Source: Na

Feb 6, 2026 @ 12:00 PM Immunovant Provides Corporate Updates and Reports ... Source: Immunovant, Inc.

Dec 18, 2025 @ 7:35 AM Is Immunovant Stock a Buy After Roivant Sciences I... Source: Robert Izquierdo

Financials
	TTM	Q4 2026	FY 2026
Basic EPS	$-2.77	$-.73	$-2.77
Diluted EPS	$-2.77	$-.73	$-2.77
Revenue
Gross Profit
Net Income / Loss	$-505.61M	$-147.86M	$-505.61M
Operating Income / Loss
Cost of Revenue
Net Cash Flow	$188.14M	$188.83M	$188.14M
PE Ratio